API
CLB icon

Advisor Partners II’s Core Laboratories CLB Stock Holding History

Advisor Partners II’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$279K Buy
11,622
+327
+3% +$8.03K 0.01% 999
2023
Q2 		$263K Buy
11,295
+190
+2% +$4.3K 0.01% 866
2023
Q1 		$245K Buy
11,105
+174
+2% +$4.07K 0.01% 833
2022
Q4 		$222K Sell
10,931
-186
-2% -$3.6K 0.01% 812
2022
Q3 		$150K Buy
+11,117
New +$187K 0.01% 789

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisor Partners II's CLB Position: Q3 2023 in Review

Advisor Partners II increased its Core Laboratories (CLB) stake by 2.9% in Q3 2023, buying an estimated $8.03K and bringing the position to 11,622 shares worth $279K. The position accounts for 0.01% of the portfolio, ranked #999.

Advisor Partners II first reported a position in CLB in Q3 2022 and has held it in 5 quarters since. 178 funds tracked by Wall St. Rank hold CLB as of Q3 2023.

  • Advisor Partners II held 11,622 shares of Core Laboratories worth $279K as of Q3 2023.
  • Advisor Partners II bought 327 Core Laboratories shares in Q3 2023, an estimated $8.03K.
  • Core Laboratories made up 0.01% of Advisor Partners II's portfolio in Q3 2023, its #999 holding.
  • Advisor Partners II first reported a position in Core Laboratories in Q3 2022 and has held it in 5 quarters since.
  • 178 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.